Jun 18, 2021 | COVID-19, News
COVID-19 vaccination in patients with α1-antitrypsin deficiency Chengliang Yang Hedi Zhao Published: June 17, 2021: COVID-19 is continuing its spread across the world, generating a wake of devastating health, economic, and social consequences. The urgency of the...
Apr 20, 2021 | COVID-19, News
Updated COVID-19 Guidance for Alphas STATEMENT UPDATED: April 16, 2021 Please note, this statement is specific to the United States. If you are an individual with Alpha-1 Antitrypsin Deficiency (Alpha-1) living outside the U.S., please see the specific statements...
Mar 22, 2021 | COVID-19, News, Uncategorized
Readers discuss equity issues in U.S. eligibility and the decision to send some of the U.S. stockpile to other countries. To the Editor: Re “U.S. Rushes to Expand Covid Vaccine Eligibility in a ‘Race Against Time’” (nytimes.com, March 19): It is encouraging to read...
Mar 12, 2021 | COVID-19, News
The Alpha-1 Foundation received the following correspondence from the National Organization for Rare Disorder’s policy team on March 12th, 2021: President Biden signed the American Rescue Plan into law on Thursday, March 11th! This law contains many important...
Jan 26, 2021 | COVID-19, News
Summary of major changes: Beginning two weeks after the second dose of a two dose vaccine, it will not be necessary for a fully vaccinated individual to quarantine after exposure to a known COVID-19 individual unless symptoms develop or unless the exposure took place...
Jan 14, 2021 | COVID-19, News
The Alpha-1 Foundation has created a letter template for Alpha-1 patients to qualify for early immunization against COVID-19. The Centers for Disease Control and Prevention (CDC), the National Academy of Medicine, and state health authorities have worked hard to...
